Energy News Portal

Sustainable

Bionyra brings in $165M for next-generation immune drugs

Source: BioPharma Dive - Latest News

The biotech, co-founded by Sofinnova Partners and a former Sanofi immunology R&D head, is testing new biologics against common immune conditions.

View Original Coverage